GlassScriptPhysician profile
Tiffany Hill
NPI 1316280597
$687.18
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148 · 2020: $104 · 2021: $65.13 · 2022: $130 · 2023: $91.93 · 2024: $149.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $241.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Insulet Corporation | $181.65 | 2019-2021 | |
| Inspire Medical Systems, INC. | $115.32 | 2024 | Inspire |
| Gilead Sciences, INC. | $106.18 | 2020-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $65.01 | 2020 | |
| Novo Nordisk INC | $31.89 | 2023-2024 | Wegovy |
| Dexcom, INC. | $20.33 | 2023 | Dexcom G6 Transmitter |
| Bayer Healthcare Pharmaceuticals INC. | $17.30 | 2023 | |
| Boston Scientific Corporation | $17.25 | 2024 | Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $15.80 | 2023 | Inpen Smart Insulin Delivery System |
| Xeris Pharmaceuticals, INC. | $15.77 | 2020 | |
| Glaxosmithkline, LLC. | $11.38 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tiffany Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.